Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Ekterly (sebetralstat) the First and Only Oral On-demand Treatment for Hereditary Angioedema (HAE)

CAMBRIDGE, Mass. & SALISBURY, England, July 7, 2025 (BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food...

NIH to Cap Publishing Fees for Publicly Funded Research

The National Institutes of Health announced it will put a limit on publisher fees for publicly funded research by Fiscal Year 2026.According to the NIH,...

New Framework Reclassifies Nearly 20 Percent of People as Having Obesity

The European Association for the Study of Obesity (EASO) framework may offer a more sensitive measure of obesity than traditional body mass index (BMI),...

Inflammatory Activity With IBD Tied to Impaired Sleep

Impaired sleep is associated with inflammatory activity in inflammatory bowel disease (IBD), but not symptoms, according to a study published online June...

Obstructive Sleep Apnea Tied to Poor Outcomes in U.S. Soldiers

Sleep disorders such as obstructive sleep apnea (OSA) contribute to mental health challenges, traumatic injuries, and increased health care utilization...

Increase in Chronic Digestive Disorders Seen During Pandemic

There was an increase in disorders of gut-brain interaction (DGBI) during the COVID-19 pandemic for those living in the United States, according to a study...

Barbie's Latest Look? It Includes an Insulin Pump and Glucose Monitor

WEDNESDAY, July 9, 2025 — Barbie’s latest look includes a polka-dot crop top, chunky heels — and an insulin pump. Mattel has released...

First Malaria Drug Approved for Newborns and Small Babies, Coartem Baby

WEDNESDAY, July 9, 2025 — A new malaria treatment has been approved for newborns and infants under 11 pounds, filling a major gap in care for some...

RFK Jr. Praises Meal Program Critics Say Is Ultra-Processed

WEDNESDAY, July 9, 2025 — A government-backed meal delivery service for people on Medicaid and Medicare is getting national attention — but...

Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis

Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for differentiated...

Is One Type of Water Healthier Than Another? Here’s What Experts Say

SUNDAY, July 6, 2025 — Alkaline. Electrolyte. Flavored. Walk down the beverage aisle and you’ll find all kinds of waters promising extra health...

Read more news...

Recently Added

Recently added consumer and prescribing information: Zegfrovy, Lynozyfic, Arynta, Harliku, Ibtrozi, Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Ekterly Ekterly (sebetralstat) is an oral plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema attacks in adults and...
  • Lynozyfic Lynozyfic (linvoseltamab-gcpt) is a bispecific B-cell maturation antigen (BCMA)‑directed CD3 T-cell engager for the treatment of relapsed o...
  • Zegfrovy Zegfrovy (sunvozertinib) is an oral, irreversible, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) for the...

More FDA approvals